A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses

Adel M. Talaat, Rick Lyons, Stephen Johnston

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Combined/composite vaccines should be useful in reducing the number of vaccinations and provide more flexibility in confronting biological warfare scenarios. We tested the effectiveness of a composite genetic vaccine designed from previously known protective antigens directed against influenza A virus (INF-A), herpes simplex virus type-1 (HSV-1) and respiratory syncytial virus (RSV) in a mouse-based challenge. Immunizing mice with a pool of four plasmids; INF-A haemagglutinin (HA), INF-A nucleoprotein (NP), HSV-1 glycoprotein D (gD) and RSV glycoprotein F, against the three pathogens provided full protection when mice were challenged with each pathogen. Remarkably, mice challenged with all three pathogens at once were also fully protected, even when a bacterial pathogen, Mycoplasma pulmonis, was included in the challenge. If these results are extendable to other combinations of vaccines in other hosts, it would support the development of gene vaccines as multi-component, combination vaccines.

Original languageEnglish (US)
Pages (from-to)538-544
Number of pages7
JournalVaccine
Volume20
Issue number3-4
DOIs
StatePublished - Nov 12 2001
Externally publishedYes

Fingerprint

Combined Vaccines
herpes simplex
Herpes Simplex
Respiratory Syncytial Viruses
Coinfection
mixed infection
influenza
Human Influenza
vaccines
viruses
Influenza A virus
Human Herpesvirus 1
Human herpesvirus 1
pathogens
mice
Glycoproteins
Mycoplasma pulmonis
Biological Warfare
Vaccines
glycoproteins

Keywords

  • Combination/composite vaccine
  • HSV
  • Influenza A
  • RSV

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses. / Talaat, Adel M.; Lyons, Rick; Johnston, Stephen.

In: Vaccine, Vol. 20, No. 3-4, 12.11.2001, p. 538-544.

Research output: Contribution to journalArticle

@article{19f309b2eefe4095807e6dd395de51b4,
title = "A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses",
abstract = "Combined/composite vaccines should be useful in reducing the number of vaccinations and provide more flexibility in confronting biological warfare scenarios. We tested the effectiveness of a composite genetic vaccine designed from previously known protective antigens directed against influenza A virus (INF-A), herpes simplex virus type-1 (HSV-1) and respiratory syncytial virus (RSV) in a mouse-based challenge. Immunizing mice with a pool of four plasmids; INF-A haemagglutinin (HA), INF-A nucleoprotein (NP), HSV-1 glycoprotein D (gD) and RSV glycoprotein F, against the three pathogens provided full protection when mice were challenged with each pathogen. Remarkably, mice challenged with all three pathogens at once were also fully protected, even when a bacterial pathogen, Mycoplasma pulmonis, was included in the challenge. If these results are extendable to other combinations of vaccines in other hosts, it would support the development of gene vaccines as multi-component, combination vaccines.",
keywords = "Combination/composite vaccine, HSV, Influenza A, RSV",
author = "Talaat, {Adel M.} and Rick Lyons and Stephen Johnston",
year = "2001",
month = "11",
day = "12",
doi = "10.1016/S0264-410X(01)00352-8",
language = "English (US)",
volume = "20",
pages = "538--544",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "3-4",

}

TY - JOUR

T1 - A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses

AU - Talaat, Adel M.

AU - Lyons, Rick

AU - Johnston, Stephen

PY - 2001/11/12

Y1 - 2001/11/12

N2 - Combined/composite vaccines should be useful in reducing the number of vaccinations and provide more flexibility in confronting biological warfare scenarios. We tested the effectiveness of a composite genetic vaccine designed from previously known protective antigens directed against influenza A virus (INF-A), herpes simplex virus type-1 (HSV-1) and respiratory syncytial virus (RSV) in a mouse-based challenge. Immunizing mice with a pool of four plasmids; INF-A haemagglutinin (HA), INF-A nucleoprotein (NP), HSV-1 glycoprotein D (gD) and RSV glycoprotein F, against the three pathogens provided full protection when mice were challenged with each pathogen. Remarkably, mice challenged with all three pathogens at once were also fully protected, even when a bacterial pathogen, Mycoplasma pulmonis, was included in the challenge. If these results are extendable to other combinations of vaccines in other hosts, it would support the development of gene vaccines as multi-component, combination vaccines.

AB - Combined/composite vaccines should be useful in reducing the number of vaccinations and provide more flexibility in confronting biological warfare scenarios. We tested the effectiveness of a composite genetic vaccine designed from previously known protective antigens directed against influenza A virus (INF-A), herpes simplex virus type-1 (HSV-1) and respiratory syncytial virus (RSV) in a mouse-based challenge. Immunizing mice with a pool of four plasmids; INF-A haemagglutinin (HA), INF-A nucleoprotein (NP), HSV-1 glycoprotein D (gD) and RSV glycoprotein F, against the three pathogens provided full protection when mice were challenged with each pathogen. Remarkably, mice challenged with all three pathogens at once were also fully protected, even when a bacterial pathogen, Mycoplasma pulmonis, was included in the challenge. If these results are extendable to other combinations of vaccines in other hosts, it would support the development of gene vaccines as multi-component, combination vaccines.

KW - Combination/composite vaccine

KW - HSV

KW - Influenza A

KW - RSV

UR - http://www.scopus.com/inward/record.url?scp=0035851350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035851350&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(01)00352-8

DO - 10.1016/S0264-410X(01)00352-8

M3 - Article

C2 - 11672920

AN - SCOPUS:0035851350

VL - 20

SP - 538

EP - 544

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 3-4

ER -